Home > PJ (current issue) > News / Daily News | Search

The Pharmaceutical Journal
Vol 272 No 7290 p305-312
13 March 2004


News summary

DIARY   Branch meetings   Future Events   Conferences

305 Omeprazole goes over-the-counter as Zanprol Omeprazole 10mg has been launched by GlaxoSmithKline Consumer Healthcare as a pharmacy-only medicine. Zanprol will be available in pharmacies for the treatment of reflux-like symptoms (eg, heartburn) in adults from 16 March ...more

305 Date set for summary judgment hearing The application for summary judgment of the Royal Pharmaceutical Society's Charter petition claim will not be heard in the High Court before mid-May, despite efforts by the Society to have the matter resolved as early as possible ...more

306 “Move or lose” contract threat in Scottish proposals Scottish community pharmacies that are too near to each other are to be encouraged to relocate to areas of under-provision or risk losing their NHS contracts. This proposal follows the rejection in Scotland of the Office of Fair Trading's proposals to overhaul control of entry regulations ...more

306 Pharmacists to be on new committees by right Pharmacists in Scotland are to have guaranteed seats on new community health partnership (CHP) committees that are to evolve from local health care co-operatives. Pharmacists were not included in LHCCs ...more

306 Money for deprived areas Funding for pilot projects that aim to improve access to health care in deprived communities in Scotland was announced last month ...more

307 Do not use risperidone or olanzapine to treat behavioural problems associated with dementia Risperidone (Risperdal) and olanzapine (Zyprexa) should not be used to treat behavioural problems in older people with dementia, recommends the Committee on Safety of Medicines. However, the new advice is likely to cause problems for health professionals managing this group of patients, a mental health pharmacist has warned ...more

307 Risk of cognitive decline lower for women treated with oral hypoglycaemics Taking oral hypoglycaemic agents can lower the risk of cognitive decline in elderly women with type 2 diabetes, and may therefore reduce their likelihood of developing dementia ...more

307 Coffee drinking linked with reduced risk for diabetes Researchers have found that drinking coffee reduces the risk for type 2 diabetes in a trial of Finnish adults ...more

308 Study confirms intensive lipid lowering is best Intensive lowering of LDL-cholesterol reduces deaths and cardiovascular events in patients with acute coronary syndromes significantly more than moderate lipid lowering, according to a major study reported this week at the American College of Cardiology meeting held in New Orleans ...more

308 Latest HPS data reveal benefits of statins on stroke in detail Latest data from the Medical Research Council/British Heart Foundation Heart Protection Study (HPS) show the beneficial effects of statins on stroke are almost entirely restricted to the most common, ischaemic form of the disease — currently responsible for about nine out of 10 strokes in the UK ...more

308 Rosuvastatin improves dyslipidaemia in patients with metabolic syndrome According to results from the largest study yet to investigate statin treatment for patients suffering from metabolic syndrome, the HMG CoA reductase inhibitor, rosuvastatin (Crestor), significantly improves all lipid abnormalities associated with the atherogenic dyslipidaemia seen in these patients ...more

308 Call for Crestor ban in US A US consumer group has written to the Food and Drug Administration demanding that rosuvastatin (Crestor) be removed from the market ...more

308 Fruit and cereals best for CHD Eating fibre from fruits and cereals, but not from vegetables, is linked with lower coronary heart disease risk ...more

309 Government proposes to regulate herbalists and acupuncturists Proposals to register and regulate herbalists and acupuncturists under a statutory scheme have been put forward by the UK government. Consultation on plans to establish a Complementary and Alternative Medicine Council continues until 7 June ...more

309 Emergency exemption for chemical warfare antidote injections Antidotes to chemical warfare agents are likely to be added to the list of medicines that can be injected by anybody to save life in an emergency ...more

309 CHI failed to deliver what ministers expected The Commission for Health Improvement, which is to be replaced by the Commission for Healthcare Audit and Inspection next month, was a victim of tension between the role it was given by legislation and the expectations of ministers, a new report reveals ...more

309 Barry Shooter Pharmacies best to work for Barry Shooter Pharmacies came fourth in The Sunday Times 2004 list of “50 best SMEs [small to medium enterprises] to work for”. Company profiles are listed in rank order and benefits such as annual leave, share ownership and child care are indicated ...more

310 Little evidence for using combination inhalers as first choice for patients with chronic lung disease It is difficult to justify using the combination inhalers Seretide (fluticasone and salmeterol) or Symbicort (budesonide and formoterol) as a first choice in managing patients with chronic obstructive pulmonary disease, according to a review ...more

310 Sildenafil appears safe and effective for some heart failure patients Sildenafil (Viagra) may be safe and effective for the treatment of erectile dysfunction in carefully selected men with moderate heart failure, a small trial indicates ...more

310 Small risk of gastric bleeding with SSRI antidepressants Any risk of gastrointestinal bleeding in patients taking selective serotonin reuptake inhibitors is small, according to this month's Drug and Therapeutics Bulletin ...more

310 NHS national staff survey Forty-seven per cent of NHS staff report seeing an error over the previous month that could have hurt either staff or patients, according to the results of the first NHS national staff survey ...more

311 Latest BNF includes updated information on HRT, approved drug names and malaria prevention BNF 47, the latest edition of the British National Formulary, contains up-to-date information on hormone replacement therapy, changes to approved drug names and new guidance on preventing malaria ...more

311 Dictation proves unpopular as way to report errors Dictating information into cassette recorders does not appear to be a popular method for community pharmacists to report prescribing interventions, US researchers have found. However, its is feasible and warrants further investigation. The researchers say that interventions to correct errors on prescriptions should be documented to provide evidence of this pharmacy service ...more


R & D

312 Omapatrilat remains on file for regulatory approval as new trial broadly favours risk-benefit ratio Indications for omapatrilat — a new antihypertensive agent being developed by Bristol-Myers Squibb — continue to be investigated while the company evaluates its options for the drug, following a new trial ...more

312 Oral E coli vaccine moving into phase II trials Protection against travellers' diarrhoea has moved a step closer ...more

312 Anti-obesity drug also helps smokers avoid weight gain Smokers and overweight patients with dyslipidaemia could benefit from a new drug being tested in clinical trials ...more

312 Polymer link reduces toxicity Researchers have reduced toxicity of an anti-tumour drug by linking it to a polymer ...more

312 Smallpox vaccine A new smallpox vaccine shows promise in animal studies. Monkeys treated with the modified vaccinia virus Ankara (MVA) were immune to monkeypox (similar to smallpox in humans) ...more

312 New breast cancer treatment Exemestane, a new aromatase inhibitor, has shown promise in primary breast cancer ...more

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal